Pazib 400MG Tablet, containing the active ingredient Pazopanib at a dosage of 400mg, is a targeted therapy primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. This medication works by inhibiting multiple tyrosine kinases, which are enzymes involved in the signaling pathways that promote tumor growth and angiogenesis (the formation of new blood vessels that supply tumors). By blocking these pathways, Pazib helps to slow down or stop the growth of cancer cells. The tablet is typically prescribed for patients who have not responded to other treatments or for whom other therapies are not suitable. It is essential for patients to follow their healthcare provider’s instructions regarding the use of this medication to achieve optimal results. Pazib is available in a pack of 30 tablets, making it convenient for patients to manage their treatment regimen.